These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 26928545)

  • 1. GPCR-radioligand binding assays.
    Flanagan CA
    Methods Cell Biol; 2016; 132():191-215. PubMed ID: 26928545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
    Wittmann HJ; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.
    Casadó-Anguera V; Moreno E; Mallol J; Ferré S; Canela EI; Cortés A; Casadó V
    Pharmacol Res; 2019 Jan; 139():337-347. PubMed ID: 30472462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer and competitive allosteric modulation model for G-protein-coupled receptors.
    Pietra D; Borghini A; Breschi MC; Bianucci AM
    J Theor Biol; 2010 Dec; 267(4):663-75. PubMed ID: 20800599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based ligand binding assays on adenosine A1 and A2A receptors.
    Massink A; Holzheimer M; Hölscher A; Louvel J; Guo D; Spijksma G; Hankemeier T; IJzerman AP
    Purinergic Signal; 2015 Dec; 11(4):581-94. PubMed ID: 26482925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scintillation proximity assay (SPA) as a new approach to determine a ligand's kinetic profile. A case in point for the adenosine A1 receptor.
    Xia L; de Vries H; IJzerman AP; Heitman LH
    Purinergic Signal; 2016 Mar; 12(1):115-26. PubMed ID: 26647040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of allosteric interactions at G protein-coupled receptors using radioligand binding assays.
    Leach K; Sexton PM; Christopoulos A
    Curr Protoc Pharmacol; 2011 Mar; Chapter 1():Unit 1.22. PubMed ID: 21935902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Horizons on Molecular Pharmacology Applied to Drug Discovery: When Resonance Overcomes Radioligand Binding.
    Pernomian L; Gomes MS; Moreira JD; da Silva CHTP; Rosa JMC; Cardoso CRB
    Curr Radiopharm; 2017; 10(1):16-20. PubMed ID: 28183248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioligand Binding Assays for Determining Dissociation Constants of Phytohormone Receptors.
    Hellmuth A; Calderón Villalobos LI
    Methods Mol Biol; 2016; 1450():23-34. PubMed ID: 27424743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptor.
    Bosma R; Stoddart LA; Georgi V; Bouzo-Lorenzo M; Bushby N; Inkoom L; Waring MJ; Briddon SJ; Vischer HF; Sheppard RJ; Fernández-Montalván A; Hill SJ; Leurs R
    Sci Rep; 2019 May; 9(1):7906. PubMed ID: 31133718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel GABAA antagonist [3H]SR 95531: microscopic analysis of binding in the rat brain and allosteric modulation by several benzodiazepine and barbiturate receptor ligands.
    McCabe RT; Wamsley JK; Yezuita JP; Olsen RW
    Synapse; 1988; 2(2):163-73. PubMed ID: 2844001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin.
    Bradfield CA; Kende AS; Poland A
    Mol Pharmacol; 1988 Aug; 34(2):229-37. PubMed ID: 2842655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological basis of receptor binding.
    Schütz W
    Wien Klin Wochenschr; 1991; 103(15):438-42. PubMed ID: 1656614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 125I-neuropeptide Y and 125I-peptide YY bind to multiple receptor sites in rat brain.
    Walker MW; Miller RJ
    Mol Pharmacol; 1988 Dec; 34(6):779-92. PubMed ID: 2849045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of radioligand specific activity using competition binding assays.
    Wiener HL; Reith ME
    Anal Biochem; 1992 Nov; 207(1):58-62. PubMed ID: 1489100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detecting ligand interactions with G protein-coupled receptors in real-time on living cells.
    Xu B; Varasteh Z; Orlova A; Andersson K; Larhammar D; Björkelund H
    Biochem Biophys Res Commun; 2013 Nov; 441(4):820-4. PubMed ID: 24211197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro receptor binding assays: general methods and considerations.
    Bigott-Hennkens HM; Dannoon S; Lewis MR; Jurisson SS
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):245-53. PubMed ID: 18475249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of competitive radioligand binding predicted by the law of mass action.
    Motulsky HJ; Mahan LC
    Mol Pharmacol; 1984 Jan; 25(1):1-9. PubMed ID: 6708928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.